Overview
- The administration has suspended roughly $300 million in annual contributions until Gavi demonstrates steps to re-earn public trust
- Gavi says its vaccine procurement follows a rigorous, transparent review process led by WHO’s Strategic Advisory Group of Experts
- Donors have pledged $9 billion toward Gavi’s $11.9 billion target for 2026–2030, securing funding for 500 million childhood vaccinations despite the U.S. withdrawal
- Public health experts warn that cutting American support risks reversing immunization gains in low-income countries and could lead to significant loss of life
- The decision continues a broader trend of reduced U.S. engagement with international health initiatives under the current administration